SCHEMBL12323830

SCHEMBL12323830

CN1C(=O)C2CN(c3ccccc3)CCN2c2nc(Cl)ncc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.49
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 4/20 0.37
DHFR P00374 3/20 0.37
CYP2D6 P10635 1/20 0.37
GSK3B P49841 1/20 0.37
MAPK1 P28482 2/20 0.36
TSHR P16473 2/20 0.36
GAA P10253 2/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.36
HCRTR2 O43614 3/20 0.35
HPGD P15428 2/20 0.35
POLB P06746 1/20 0.35
ATM Q13315 1/20 0.35
HCRTR1 O43613 1/20 0.35
HSD17B10 Q99714 1/20 0.34
PIN1 Q13526 1/20 0.34
ABL1 P00519 1/20 0.34
BCR P11274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12323364 1.00 MAPT (0.49) MAPTSMN1; SMN2ALDH1A1DHFRCYP2D6
SCHEMBL12323363 0.79 SMN1; SMN2 (0.35) SMN1; SMN2GSK3BABL1BCR
SCHEMBL12324580 0.79 SMN1; SMN2 (0.35) SMN1; SMN2GSK3BABL1BCR
SCHEMBL12323366 0.77 MAPT (0.50) MAPTSMN1; SMN2ALDH1A1CYP2D6GSK3B
SCHEMBL12323371 0.77 NR1H2 (0.40) SMN1; SMN2CYP2D6KMT2ANPC1
SCHEMBL2340384 0.77 ALDH1A1 (0.41) MAPTSMN1; SMN2ALDH1A1TSHRGAA
SCHEMBL2340390 0.77 ALDH1A1 (0.41) MAPTSMN1; SMN2ALDH1A1TSHRGAA
SCHEMBL2050138 0.76 BRD4 (0.40) MAPTSMN1; SMN2ALDH1A1TSHRKMT2A
SCHEMBL2050140 0.76 BRD4 (0.40) MAPTSMN1; SMN2ALDH1A1TSHRKMT2A
SCHEMBL12323370 0.75 KRAS (0.37) SMN1; SMN2ABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011113293-A1 DIHYDROPTERIDINONE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 江苏恒瑞医药股份有限公司 (CN) 2011-09-22 WO disclosed